Natus Medical Net Income Per Employee Trend

BABY -- USA Stock  

USD 36.35  0.40  1.09%

This module enables investors to look at Natus Medical various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 42.4 M, Cost of Revenue of 152.7 M or Earning Before Interest and Taxes EBIT of 56.5 M, but also many exotic indicators such as Interest Coverage of 194, Long Term Debt to Equity of 0.1056 or Calculated Tax Rate of 32.5157. This module is a perfect complement to use when analyzing Natus Medical Valuation or Volatility. It can also complement various Natus Medical Technical models. Check also analysis of Natus Medical Correlation with competitors.
Showing smoothed Net Income Per Employee of Natus Medical Incorporated with missing and latest data points interpolated.
Net Income Per Employee10 Years Trend
Increasing
Slightly volatile
 Net Income Per Employee 
      Timeline 

Regression Statistics

Arithmetic Mean  23,837
Coefficient Of Variation  65.30
Mean Deviation  11,532
Median  24,261
Standard Deviation  15,565
Range  55,823
R Value  0.43
R Squared  0.19
Significance  0.14
Slope  1,722

Natus Medical Net Income Per Employee Over Time

2016-12-31  35,543 
2017-12-31  35,543 
2018-12-31  41,815 

Other Fundumenentals

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Upcoming Events

Natus Medical Upcoming Company Events
Upcoming Quarterly ReportApril 19, 2017
Next Earnings ReportJuly 19, 2017
Check also analysis of Natus Medical Correlation with competitors. Please also try Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.